APA aipamena

KALRA, N., ASHAI, A., XI, L., ZHANG, J., AVITAL, I., RAFFELD, M., & HASSAN, R. (2012). Patients with peritoneal mesothelioma lack epidermal growth factor receptor tyrosine kinase mutations that would make them sensitive to tyrosine kinase inhibitors. Oncol Rep.

Chicago Style aipamena

KALRA, NEETU, ALI ASHAI, LIQIANG XI, JINGLI ZHANG, ITZHAK AVITAL, MARK RAFFELD, and RAFFIT HASSAN. "Patients With Peritoneal Mesothelioma Lack Epidermal Growth Factor Receptor Tyrosine Kinase Mutations That Would Make Them Sensitive to Tyrosine Kinase Inhibitors." Oncol Rep 2012.

MLA aipamena

KALRA, NEETU, et al. "Patients With Peritoneal Mesothelioma Lack Epidermal Growth Factor Receptor Tyrosine Kinase Mutations That Would Make Them Sensitive to Tyrosine Kinase Inhibitors." Oncol Rep 2012.